Four-Week Therapy With Peginterferon Alfa-2B/Ribavirin Effectively Predicts Sustained Virologic Response in Treatment-NaïVE and Previous-Treatment-Failure Patients With HCV-1 Treated With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin

✍ Scribed by Vierling, John M. ;Lawitz, Eric J. ;Poordad, Fred ;Sulkowski, Mark ;Bourliere, Marc ;Buti, Maria ;Cooper, Curtis ;Galati, jOSEPH ;Albrecht, Janice K. ;Boparai, Navdeep ;Brass, Clifford A. ;Burroughs, Margaret ;Sniukiene, Vilma ;Bruno, Savino

• Book ID: 122238328
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 431 KB
• Volume: 140
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(11)63768-2